GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Klotho Neurosciences Inc (NAS:KLTO) » Definitions » ROE % Adjusted to Book Value

KLTO (Klotho Neurosciences) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Klotho Neurosciences ROE % Adjusted to Book Value?

Klotho Neurosciences's ROE % for the quarter that ended in Sep. 2024 was 0.00%. Klotho Neurosciences's PB Ratio for the quarter that ended in Sep. 2024 was 9.49. Klotho Neurosciences's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 0.00%.

Klotho Neurosciences ROE % Adjusted to Book Value Historical Data

The historical data trend for Klotho Neurosciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Klotho Neurosciences ROE % Adjusted to Book Value Chart

Klotho Neurosciences Annual Data
Trend Dec21 Dec22
ROE % Adjusted to Book Value
- -

Klotho Neurosciences Quarterly Data
Dec21 Jun22 Dec22 Jun23 Sep23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial - - - - -

Competitive Comparison of Klotho Neurosciences's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Klotho Neurosciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Klotho Neurosciences's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Klotho Neurosciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Klotho Neurosciences's ROE % Adjusted to Book Value falls into.


Klotho Neurosciences ROE % Adjusted to Book Value Calculation

Klotho Neurosciences's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-54.33% / N/A
=N/A

Klotho Neurosciences's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / 9.49
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Klotho Neurosciences ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Klotho Neurosciences's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Klotho Neurosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Klotho Neurosciences Inc (NAS:KLTO) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
KPRX CHRO BCDA BCLI AEON INDP AIM ORGS CELZ ENZN VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
13576 Walnut Street, 12th Floor, Omaha, NE, USA, 68144
Website
https://www.klothoneuro.com
Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.